about
A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosusDefining the functional states of Th17 cellsA Dormant Microbial Component in the Development of PreeclampsiaIL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasisTh17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa.Resistin enhances the expansion of regulatory T cells through modulation of dendritic cells.Th17 cytokines and vaccine-induced immunity.Th17 cytokines in mucosal immunity and inflammation.Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunityRole of heat-stable enterotoxins in the induction of early immune responses in piglets after infection with enterotoxigenic Escherichia coli.Update on ankylosing spondylitis: current concepts in pathogenesis.IL-17 and Th17 cells in tuberculosisAssociation between short sleep duration and the risk of sensitization to food and aero allergens in rural Chinese adolescentsInvestigating the relationship between serum interleukin-17 levels and systemic immune-mediated disease in patients with dry eye syndromeInterleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infectionB cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response.Trp53 negatively regulates autoimmunity via the STAT3-Th17 axis.Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis.IL-27 imparts immunoregulatory function to human NK cell subsets.The T cell response to IL-10 alters cellular dynamics and paradoxically promotes central nervous system autoimmunityMolecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndromeClinical impact of immunomonitoring in the treatment of inflammatory bowel disease.Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis.Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.Molecular mechanisms of the immunological abnormalities in hyper-IgE syndrome.The pathology of Mycobacterium tuberculosis infection.The role of Tec family kinases in the regulation of T-helper-cell differentiation.Possible roles of IL-12-family cytokines in rheumatoid arthritis.Immunomodulatory effects of heat-killed Enterococcus faecalis TH10 on murine macrophage cells.Enhancing the specificity of T-cell cultures for adoptive immunotherapy of cancer.A novel class of anti-IL-12p40 antibodies: potent neutralization via inhibition of IL-12-IL-12Rβ2 and IL-23-IL-23R.New developments in C5a receptor signaling.The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling.Signaling events involved in interleukin 27 (IL-27)-induced proliferation of human naive CD4+ T cells and B cells.miR26a modulates Th17/T reg balance in the EAE model of multiple sclerosis by targeting IL6.Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients.Mouse model of primary biliary cirrhosis with progressive fibrosis: are we there yet?Dermal Vγ4+T cells enhance the IMQ-induced psoriasis-like skin inflammatidon in re-challenged mice.
P2860
Q24629130-414AF1FA-76ED-402E-ACED-19684874D700Q26998296-5FE4ECAD-89C7-4F9D-9C21-BCC56DBB1162Q28069689-A208A993-555D-48B5-8D92-5098DD9406D2Q28268370-F892D01E-B5AE-421F-B2FB-91EF9A763FFEQ33611067-F06098CE-88A9-40DA-9EC9-E0E4C8B729C0Q33622026-7AE303D4-5928-42B5-A299-E54A1281A549Q33792227-2ED8B33E-8BDA-4FA5-8762-C6E3AA6BF07DQ33943805-C8CB051F-1EFB-4FA4-BCAF-32D4DB60172BQ34044412-5E5BA12D-CB5D-46A5-9550-C4D5563066FEQ34345547-234D00F4-6183-496F-9CAF-4D58BF577965Q34450732-C740C8D9-B33E-4045-AB0A-E58BE950BAB0Q34545889-89ACF706-ABE8-4503-BDEF-10A980F7D3DBQ34669478-BC909056-6A4F-4575-AD94-5065E692F944Q34695038-26DDFE3F-B07A-4C14-8AB8-97027558FD07Q34739767-0A803E2C-02FE-40B1-B6FA-7BF89425152DQ34819635-109CAEEA-C097-4BDE-900E-0EB9AA228894Q35043885-3C586F2E-0D4C-4D1E-A939-CCE2FD2607D6Q35196679-8E05C8C4-47AB-4F53-B73F-F4F78312B067Q35409867-5E6F2795-1D94-4AB0-AE66-29D20E715BEEQ36084245-0E465EC4-0772-472E-891D-12A938F4C8E1Q37273205-06AB8AC6-2161-4F61-A7CF-696E8157ACC6Q37624487-CB54C43B-039F-4203-9419-A9621D6579ABQ37652760-2181F707-4FE6-4993-86F0-8A16DBB9A888Q37866627-F09C80F1-B5E9-451B-9FD5-1EFB0D0C3B0DQ37974983-B908B767-A0B0-4BDA-8416-9EAD2C6DDDD5Q37977379-E0393EC6-DCAE-4A9D-9B9B-3EB06639D9AFQ37997076-0C08D6C5-54E1-473B-A881-6C01C3EB1BF9Q38054543-A8C2FE86-6198-48E2-8D53-93099C70F961Q39227463-A9B0A08C-2804-4F77-8316-9DF98409C2B6Q39617589-8DEBF9F6-D3BA-48D6-B9B4-C9C9EC99A9BFQ39665431-0401DCE5-9673-47F0-99A2-3A6AA0E74892Q39669824-22E8E47C-8768-40DF-8C00-FECA0897F9D2Q39806420-8ECCA464-0C1A-4D94-9722-15571E44BDB1Q41887169-822CAB97-53AE-4C45-9299-DA7C94B0FB2DQ42182365-39F65ADC-7F2B-4414-A7B7-CF235E3B3194Q44234056-403F6943-1DDB-4F6D-9875-7E11F8B7F9F0Q46186395-C9EACD66-B327-4F2E-B15C-BD7B2B50CBC5Q49214146-C51B750F-E268-4BA0-94E4-9FF4C78D7824
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytokines that regulate autoimmunity.
@en
Cytokines that regulate autoimmunity.
@nl
type
label
Cytokines that regulate autoimmunity.
@en
Cytokines that regulate autoimmunity.
@nl
prefLabel
Cytokines that regulate autoimmunity.
@en
Cytokines that regulate autoimmunity.
@nl
P2093
P1476
Cytokines that regulate autoimmunity.
@en
P2093
Caroline Diveu
Daniel J Cua
Mandy J McGeachy
P304
P356
10.1016/J.COI.2008.09.003
P577
2008-10-17T00:00:00Z